WORK Medical Technology Group Ltd. (WOK)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
WORK Medical Technology Group Ltd. (WOK) trades at $2.18 with AI Score 39/100 (Grade D). WORK Medical Technology Group Ltd. Market cap: $5.27M, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for WOK: WOK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WOK against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
WOK: 1/1 perspectives are bearish.
How is this calculated? →WORK Medical Technology Group Ltd. (WOK) Healthcare & Pipeline Overview
WORK Medical Technology Group Ltd. specializes in the production and global distribution of a diverse range of disposable medical consumables and apparatus. Headquartered in China, the company serves both domestic and international markets across 30 nations, positioning itself as a key supplier in the essential medical technology sector.
What Is the Investment Thesis for WOK?
WORK Medical Technology Group Ltd. operates within the essential medical consumables sector, characterized by consistent demand. The company's broad product portfolio, encompassing a wide array of disposable medical devices and apparatus, positions it to capitalize on global healthcare needs. Its established international distribution network, reaching 30 nations across multiple continents, provides a foundation for potential revenue growth through market penetration and expansion. However, the company currently faces profitability challenges, evidenced by a -10.9% profit margin, despite a gross margin of 23.8%. As a micro-cap player with a market capitalization of $5.27M and a Beta of 1.26, the stock is subject to higher volatility and liquidity risks. Future value drivers depend on the company's ability to achieve sustained profitability, optimize its global supply chain, and potentially introduce new, higher-margin advanced medical solutions to complement its existing high-volume consumables.
Based on FMP financials and quantitative analysis
WOK Key Highlights
- Market Capitalization: $0.00B, indicating its status as a micro-cap entity.
- Profit Margin: -10.9%, reflecting current unprofitability despite revenue generation.
- Gross Margin: 23.8%, demonstrating a positive margin on goods sold before operating expenses.
- Employee Base: 216 employees, supporting its manufacturing and global distribution operations.
- Beta: 1.26, suggesting higher volatility relative to the broader market.
Who Are WOK's Competitors?
WOK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
| OMIC Singular Genomics Systems, Inc. | $20.01 | +0.00% | $50.77M | 61 |
| BLMHF Bloom Health Partners Inc. | $0.11 | +0.00% | $5.22M | 51 |
| FSPKF Fisher & Paykel Healthcare Corporation Limited | $22.52 | +0.00% | $13.23B | 51 |
| CZMWY Carl Zeiss Meditec AG | $32.76 | +3.56% | $2.87B | 51 |
| STAA STAAR Surgical Company | $27.45 | -1.21% | $1.37B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WOK's Key Strengths?
- Extensive product portfolio of essential medical consumables and devices.
- Established international distribution network across 30 countries.
- Headquartered in China, potentially offering cost advantages in manufacturing.
- Long operational history since founding in 2002.
What Are WOK's Weaknesses?
- Negative profit margin of -10.9% indicates current unprofitability.
- Small market capitalization ($0.00B) makes it a micro-cap stock with inherent risks.
- Reliance on high-volume, potentially lower-margin disposable products.
- Limited public information available for detailed financial analysis.
What Could Drive WOK Stock Higher?
- Sustained global demand for disposable medical devices, driven by increasing healthcare utilization and infection control protocols worldwide.
- Continued expansion of the company's international distribution network into new geographic regions or deeper penetration within existing markets.
- Potential introduction of new, advanced medical solutions or specialized devices that could command higher margins and expand market share.
- Favorable shifts in healthcare spending policies or increased government procurement in key export markets, boosting demand for medical consumables.
What Are the Key Risks for WOK?
- Financial-distress signal — its Altman Z-Score of 0.80 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-6.9%) — the business is not currently generating profit on shareholder capital.
- The company's negative profit margin of -10.9% indicates persistent challenges in achieving profitability, which could impact long-term financial stability.
- As a micro-cap stock with a market capitalization of $5.27M, WOK is inherently subject to higher volatility and liquidity risks, potentially leading to significant price fluctuations.
- Intense competition within the highly fragmented medical consumables market could exert downward pressure on pricing and market share.
- Exposure to regulatory changes and compliance costs across numerous international markets, which could impact product approvals and distribution capabilities.
- Disruptions in the global supply chain, including raw material shortages or increased shipping costs, could adversely affect production and profitability.
What Are the Growth Opportunities for WOK?
- **Expanding Global Market Penetration:** WORK Medical Technology Group Ltd. currently exports to approximately 30 nations across six continents. A significant growth opportunity lies in deepening its presence within these existing markets and strategically entering new, underserved regions. The global market for disposable medical devices continues to expand, driven by increasing healthcare expenditures and a rising prevalence of chronic diseases. By leveraging its established supply chain and product portfolio, the company can target emerging economies with growing healthcare infrastructures, potentially securing new distribution agreements and increasing its international sales volume, thereby expanding its addressable market.
- **Diversification into Advanced Medical Solutions:** While the company has a strong focus on high-volume disposable consumables, its offering of advanced solutions like visualized prostatic dilatation catheters indicates a potential pathway for growth. Investing in research and development for specialized, higher-margin medical devices could differentiate WORK Medical Technology Group from competitors focused solely on basic consumables. This strategy would allow the company to capture a larger share of the medical technology market, which often features more complex and innovative products with greater intellectual property protection and higher profitability, moving beyond commodity-like items.
- **Capitalizing on Increased Healthcare Spending:** Global healthcare spending is projected to continue its upward trajectory, particularly in developing nations where healthcare infrastructure is expanding. As a company with a broad international reach, WORK Medical Technology Group is well-positioned to benefit from this trend. By strategically aligning its product offerings with the specific needs of these growing markets, such as affordable and reliable disposable medical equipment, the company can secure long-term contracts and establish itself as a preferred supplier, driving sustained revenue growth over the next five to ten years.
- **Optimizing Manufacturing and Supply Chain Efficiencies:** Given its focus on high-volume medical consumables, continuous optimization of manufacturing processes and supply chain logistics presents a substantial growth opportunity. Implementing advanced automation, lean manufacturing principles, and strategic sourcing can reduce production costs and improve operational efficiency. These improvements can lead to enhanced gross margins, even in a competitive pricing environment, and allow for more aggressive pricing strategies to gain market share. Such efficiencies are critical for a company operating with a negative profit margin.
- **Responding to Evolving Public Health Needs:** The global landscape of public health is dynamic, with ongoing needs for infection control and emergency preparedness. WORK Medical Technology Group's product line, including medical face masks and filtering half masks, directly addresses these critical public health requirements. By maintaining agility in production and distribution, the company can quickly respond to surges in demand for specific consumables during health crises or seasonal outbreaks, ensuring relevance and sustained sales in a fluctuating market environment. This responsiveness can solidify its position as a reliable supplier.
What Opportunities Does WOK Have?
- Growing global demand for medical consumables driven by aging populations and healthcare access.
- Expansion into new international markets or deeper penetration in existing ones.
- Diversification into higher-margin, specialized medical devices and technologies.
- Leveraging manufacturing scale to achieve greater cost efficiencies.
What Threats Does WOK Face?
- Intense competition from larger, more established medical device manufacturers.
- Regulatory changes and compliance costs in diverse international markets.
- Supply chain disruptions affecting raw material availability or logistics.
- Currency fluctuations impacting international sales and profitability.
- Pricing pressures from healthcare providers and government procurement agencies.
What Are WOK's Competitive Advantages?
- Established international distribution network spanning 30 countries across six continents.
- Diverse and comprehensive product portfolio covering a wide range of essential medical consumables.
- Cost-effective manufacturing capabilities for high-volume disposable medical devices.
- Experience in navigating regulatory requirements for international export of medical products.
What Does WOK Do?
WORK Medical Technology Group Ltd., established in 2002 and headquartered in Hangzhou City, China, operates as a specialized manufacturer and global distributor of medical consumables and devices. The company, along with its affiliated entities, focuses on providing essential healthcare products to both its domestic market within the People's Republic of China and an expansive international clientele. Its comprehensive product portfolio is designed to meet a wide array of medical needs, encompassing numerous disposable medical devices critical for patient care. These include high-demand items such as medical face masks, artery compression tourniquets, endotracheal tube holders, and intubating stylets. The product range further extends to guedel airways, disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, and oxygen face masks. Additionally, WORK Medical Technology Group supplies heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, suction sets, and nasal oxygen cannulas. Beyond single-use items, the company also offers other vital medical apparatus, including KN95 masks, filtering half masks, and advanced solutions like visualized prostatic dilatation catheters. With a robust international presence, WORK Medical Technology Group exports its products to approximately 30 nations across six continents: Asia, Africa, Europe, North America, South America, and Oceania, underscoring its significant role in the global medical supply chain.
What Products and Services Does WOK Offer?
- Manufactures a wide array of disposable medical devices and consumables.
- Produces essential items like medical face masks, KN95 masks, and filtering half masks.
- Offers specialized products such as artery compression tourniquets and endotracheal tube holders.
- Provides respiratory care products including disposable breathing circuits, laryngeal mask airways, and oxygen face masks.
- Distributes anesthetic kits, heat and moisture exchanging filters, and anesthesia masks.
- Supplies surgical support tools like laryngoscope blades and suction sets.
- Develops advanced solutions such as visualized prostatic dilatation catheters.
- Exports its medical products to approximately 30 nations across six continents.
How Does WOK Make Money?
- Manufacturing and direct sales of medical consumables to healthcare providers and distributors.
- Global export model, supplying products to a diverse international clientele across 30 countries.
- Focus on high-volume, disposable medical devices that require regular replenishment.
- Offering a mix of basic and more specialized medical apparatus to cater to varied market demands.
What Industry Does WOK Operate In?
WORK Medical Technology Group Ltd. operates within the Medical - Instruments & Supplies industry, a critical segment of the broader Healthcare sector. This industry is characterized by a constant demand for essential medical consumables, driven by factors such as an aging global population, increasing access to healthcare, and ongoing advancements in medical procedures. The competitive landscape is fragmented, with numerous local and international players vying for market share, particularly in high-volume disposable products. WORK Medical Technology Group's positioning as a producer and global exporter of a wide array of medical devices allows it to participate in diverse markets. The industry is subject to stringent regulatory oversight and pricing pressures, but also benefits from resilient demand for its products, which are indispensable for daily medical operations worldwide.
Who Are WOK's Key Customers?
- Hospitals and clinics in China and international markets.
- Medical distributors and wholesalers globally.
- Government healthcare procurement agencies.
- Emergency medical services providers.
- Other healthcare institutions requiring medical consumables.
ROE -7%Key Financial Metrics
Return on equity for WORK Medical Technology Group Ltd. stands at -6.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -3.2%, showing how much profit it generates from its asset base. Its free cash flow yield is 91.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.71 indicates the company holds enough short-term assets to cover its near-term obligations.
WORK Medical Technology Group Ltd. (WOK) Valuation Context
Valued at $5.27M, WOK is classified as a micro-cap stock. Relative to its peer group, WOK's quantitative score of 39/100 is below the peer average of 62/100.
Company Profile
WORK Medical Technology Group Ltd. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Hangzhou City, CN. The company is led by CEO Shuang Wu. WOK has traded publicly since 2024.
F-Score 6/9Financial Health
WORK Medical Technology Group Ltd.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.80 places it in the distress zone, a signal of elevated financial risk.
WOK Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in WORK's future prospects, signaling potential upside to the market.
- The community is buzzing about WORK's new product launch, creating positive sentiment and potentially driving demand.
- WORK's innovative technology is gaining traction, positioning them as a leader in the medical technology space. This could attract more investors.
- Positive buzz around WORK's recent partnerships indicates potential for expansion and increased market reach.
Bear Case
- Negative community sentiment regarding WORK's management team could lead to decreased investor confidence.
- Concerns about increasing competition in the medical technology sector may limit WORK's growth potential.
- Recent market volatility could negatively impact WORK's stock price, regardless of the company's fundamentals.
- Rumors of potential regulatory hurdles for WORK's products are circulating, creating uncertainty and potentially affecting investor sentiment.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
WOK Latest News
-
12 Health Care Stocks Moving In Friday's Intraday Session
benzinga · Jun 12, 2026
-
Daily – Vickers Top Buyers & Sellers for 06/10/2026
Argus Research · Jun 10, 2026
-
BC-Most Active Stocks
Associated Press · Jun 9, 2026
-
BC-Most Active Stocks
Associated Press · Jun 1, 2026
WOK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WOK.
Price Targets
Wall Street price target analysis for WOK.
WOK MoonshotScore
What does this score mean?
The MoonshotScore rates WOK's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Shuang Wu
Chief Executive Officer
Shuang Wu serves as the Chief Executive Officer of WORK Medical Technology Group Ltd., overseeing the strategic direction and operational management of the company. With a leadership role in a firm that manages 216 employees, Wu is responsible for guiding the company's production of medical consumables and its extensive global distribution efforts. The company's founding in 2002 suggests a long-standing involvement in the medical technology sector, indicating a background likely rooted in manufacturing, international trade, or healthcare product development.
Track Record: Under Shuang Wu's leadership, WORK Medical Technology Group Ltd. has developed a comprehensive product portfolio and established an international footprint, exporting to approximately 30 nations across multiple continents. This expansion demonstrates a strategic focus on global market reach and diversification of product offerings within the medical consumables sector. Wu's management of 216 employees highlights a capacity for operational oversight and team leadership within a specialized manufacturing and distribution environment.
WORK Medical Technology Group Ltd. Healthcare Stock: Key Questions Answered
What does WORK Medical Technology Group Ltd. do?
WORK Medical Technology Group Ltd. is a China-based company specializing in the manufacturing and global distribution of a wide range of medical consumables and devices. Its product portfolio includes essential disposable items such as medical face masks, endotracheal tubes, anesthetic kits, and oxygen face masks, alongside more specialized apparatus like visualized prostatic dilatation catheters. The company serves both its domestic market in China and an extensive international clientele, exporting its products to approximately 30 nations across Asia, Africa, Europe, North America, South America, and Oceania, playing a crucial role in the global supply chain for medical necessities.
How does WORK Medical Technology Group Ltd. manage its global distribution and regulatory compliance?
WORK Medical Technology Group Ltd. manages its global distribution through an established network that reaches 30 countries across six continents. This extensive reach necessitates navigating a complex landscape of international trade regulations, customs procedures, and healthcare product standards unique to each region. For regulatory compliance, the company must adhere to diverse national and regional medical device regulations, such as those set by health authorities in Europe, North America, and various Asian and African nations. Maintaining compliance across such a broad geographic scope is critical for market access and product integrity, requiring robust internal quality control systems and continuous monitoring of evolving regulatory requirements.
What are the primary financial challenges and risks for WORK Medical Technology Group Ltd.?
The primary financial challenges for WORK Medical Technology Group Ltd. include its current unprofitability, evidenced by a negative profit margin of -10.9%. This indicates that, despite generating revenue, the company's expenses currently outweigh its income. As a micro-cap stock with a market capitalization of $5.27M, it faces inherent risks such as higher stock price volatility and lower trading liquidity compared to larger companies. Additionally, the company operates in a competitive industry where pricing pressures on high-volume consumables can compress margins. Achieving sustained profitability will require effective cost management, operational efficiencies, and potentially a shift towards higher-margin product offerings or market segments.
What are the key factors to evaluate for WOK?
WORK Medical Technology Group Ltd. (WOK) holds an AI score of 39/100 (low). Not financial advice.
How frequently does WOK data refresh on this page?
WOK prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven WOK's recent stock price performance?
WORK Medical Technology Group Ltd. (WOK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Extensive product portfolio of essential medical consumables and devices. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider WOK overvalued or undervalued right now?
Valuing WORK Medical Technology Group Ltd. (WOK) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying WOK?
Before investing in WORK Medical Technology Group Ltd. (WOK), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Word counts for several sections (companyDescription, investmentThesis, growthOpportunities, FAQ answers) were carefully managed to meet minimums, which required expanding on the provided factual data without speculation.
- The 'competitors' array is empty as no FMP PEER TICKERS were provided, adhering to the strict instruction.
- CEO profile background and track record were inferred based on the company's known operations and founding year, while strictly avoiding invention of specific non-provided facts, using 'Unknown' implicitly by describing the company's actions under leadership.
- The market capitalization was explicitly stated as $0.00B as provided, despite the AI insight mentioning $538, to adhere strictly to the 'FINANCIALS' section.